DrugPatentWatch Database Preview
Insulin lispro protamine recombinant; insulin lispro recombinant - Biologic Drug Details
» See Plans and Pricing
Summary for insulin lispro protamine recombinant; insulin lispro recombinant
Recent Clinical Trials for insulin lispro protamine recombinant; insulin lispro recombinant
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Universidad de Guanajuato | Phase 4 |
| Medical University of Graz | Phase 1 |
| Eli Lilly and Company | Phase 3 |
See all insulin lispro protamine recombinant; insulin lispro recombinant clinical trials
Patent Text Search: US Patents for insulin lispro protamine recombinant; insulin lispro recombinant
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | HUMALOG MIX 75/25 | insulin lispro protamine recombinant; insulin lispro recombinant | INJECTABLE;INJECTION | 021017 | 001 | 1999-12-22 | Start Trial | INDIAN INSTITUTE OF TECHNOLOGY, BOMBAY (Mumbai, IN) | 2036-02-19 | DISCN | search | |
| Lilly | HUMALOG MIX 75/25 KWIKPEN | insulin lispro protamine recombinant; insulin lispro recombinant | INJECTABLE;INJECTION | 021017 | 002 | 1999-12-22 | Start Trial | INDIAN INSTITUTE OF TECHNOLOGY, BOMBAY (Mumbai, IN) | 2036-02-19 | DISCN | search | |
| Lilly | HUMALOG MIX 75/25 PEN | insulin lispro protamine recombinant; insulin lispro recombinant | INJECTABLE;INJECTION | 021017 | 003 | 1999-12-22 | Start Trial | INDIAN INSTITUTE OF TECHNOLOGY, BOMBAY (Mumbai, IN) | 2036-02-19 | DISCN | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for insulin lispro protamine recombinant; insulin lispro recombinant
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2017141262 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for insulin lispro protamine recombinant; insulin lispro recombinant
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C0023 | France | Start Trial | PRODUCT NAME: INSULIN GLARGINE; NAT. REGISTRATION NO/DATE: EU/0/00/134/001 20000609; FIRST REGISTRATION: EU/1/00/134/001 20000609 |
| 213 | Luxembourg | Start Trial | PRODUCT NAME: INSULINE DEGLUDEC SOUS TOUTES LES FORMES PROTEGEES PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/12/807/001-4-5-7-8-9-12-13-15 TRESIBA 20130123 |
| 13C/035 | Belgium | Start Trial | PRODUCT NAME: TRESIBA-INSULINE DEGLUDEC; AUTHORISATION NUMBER AND DATE: EU/1/12/807/001 20130121 |
| C/GB05/024 | United Kingdom | Start Trial | PRODUCT NAME: INSULIN GLULISINE OR A PHYSIOLOGICALLY TOLERABLE SALT THEREOF; REGISTERED: UK EU/1/04/285/001 20040929; UK EU/1/04/285/002 20040929; UK EU/1/04/285/003 20040929; UK EU/1/04/285/004 20040929; UK EU/1/04/285/005 20040929; UK EU/1/04/285/006 20040929; UK EU/1/04/285/007 20040929; UK EU/1/04/285/008 20040929; UK EU/1/04/285/009 20040929; UK EU/1/04/285/010 20040929; UK EU/1/04/285/011 20040929; UK EU/1/04/285/012 20040929; UK EU/1/04/285/013 20040929; UK EU/1/04/285/014 20040929; UK EU/1/04/285/015 20040929; UK EU/1/04/285/016 20040929; UK EU/1/04/285/017 20040929; UK EU/1/04/285/018 20040929; UK EU/1/04/285/019 20040929; UK EU/1/04/285/020 20040929 |
| 2005 00018 | Denmark | Start Trial | PRODUCT NAME: INSULIN GLULISIN |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
